QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.108.021501v1 36/10/2058    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matsubara, T. Articles by Yamazoe, Y. Search for Related Content PubMed PubMed Citation Articles by Matsubara, T. Articles by Yamazoe, Y.

Role of Vitamin D Receptor in the Lithocholic Acid-Mediated CYP3A Induction in Vitro and in Vivo

Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan

Lipophilic bile acids are suggested to be involved in the endogenous expression of CYP3A4 in human and experimental animals as ligands of nuclear receptors. To verify the nuclear receptor specificity, the bile acid-mediated induction of CYP3A4 has been studied in vitro and in vivo in the present study. Lithocholic acid (LCA) strongly enhanced the activities of the CYP3A4 reporter gene, which contained multiple nuclear receptor binding elements, in both HepG2 and LS174T cells. The introduction of small interfering RNA for human vitamin D receptor (VDR), but not for human pregnane X receptor, reduced the LCA-induced activation of the reporter gene in these cells, suggesting the major role of VDR in the LCA induction of CYP3A4. Consistently, oral administration of LCA (100 mg/kg/day for 3 days) increased Cyp3a protein levels in the intestine but not in the liver, where a negligible level of VDR mRNA is detected. The selective role of VDR was tested in mice with the adenoviral overexpression of the receptor. Oral administration of LCA had no clear influence on the CYP3A4 reporter activity in the liver of control mice. In mice with the adenovirally expressed VDR, LCA treatment (100 or 400 mg/kg/day for 3 days) resulted in the enhanced reporter activities and increased levels of Cyp3a proteins in the liver. These results indicate the selective involvement of VDR, but not pregnane X receptor, in the LCA-mediated induction of both human and mouse CYP3As in vivo.

This article has been cited by other articles:

				S. Nishida, J. Ozeki, and M. Makishima Modulation of Bile Acid Metabolism by 1{alpha}-Hydroxyvitamin D3 Administration in Mice Drug Metab. Dispos., October 1, 2009; 37(10): 2037 - 2044. [Abstract] [Full Text] [PDF]

				Y.-Z. Pan, W. Gao, and A.-M. Yu MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting Drug Metab. Dispos., October 1, 2009; 37(10): 2112 - 2117. [Abstract] [Full Text] [PDF]

				A. K. Deo and S. M. Bandiera 3-Ketocholanoic Acid Is the Major in Vitro Human Hepatic Microsomal Metabolite of Lithocholic Acid Drug Metab. Dispos., September 1, 2009; 37(9): 1938 - 1947. [Abstract] [Full Text] [PDF]

				S. Tachibana, K. Yoshinari, T. Chikada, T. Toriyabe, K. Nagata, and Y. Yamazoe Involvement of Vitamin D Receptor in the Intestinal Induction of Human ABCB1 Drug Metab. Dispos., August 1, 2009; 37(8): 1604 - 1610. [Abstract] [Full Text] [PDF]

				S. Han and J. Y. L. Chiang Mechanism of Vitamin D Receptor Inhibition of Cholesterol 7{alpha}-Hydroxylase Gene Transcription in Human Hepatocytes Drug Metab. Dispos., March 1, 2009; 37(3): 469 - 478. [Abstract] [Full Text] [PDF]